文献速递血栓与止血

高加索人群COVID-19凝血病特征研究

COVID19 coagulopathy in Caucasian patients.
PubMed 文献 · Br J Haematol · 2020-05-17

该研究在高加索COVID-19患者中探究凝血病特征,发现重症感染与显著凝血病相关且与疾病严重程度相关;接受低分子肝素血栓预防者罕见发生显性DIC,DIC仅见于少数晚期病例。作者提出肺特异性血管病(PIC)有别于DIC,并提示肺血管病变可能解释种族间COVID-19死亡率差异。

要点

  • 重症COVID-19与显著凝血病相关,且与疾病严重程度相关。
  • 高加索患者接受低分子肝素预防时罕见显性DIC,DIC限于晚期。
  • 作者提出肺血管内凝血病(PIC)有别于DIC。

核心结论

  • 重症COVID-19感染与显著凝血病相关,且与疾病严重程度相关。
  • 接受低分子肝素血栓预防的高加索COVID-19患者罕见发生显性DIC,DIC倾向于局限于晚期疾病。
  • COVID-19弥漫性双侧肺部炎症可能与一种新型肺特异性血管病即肺血管内凝血病(PIC)相关,有别于DIC。

研究设计与样本

  • 本研究在高加索COVID-19患者中调查凝血病特征。

主要发现

  • 重症COVID-19感染与显著凝血病相关,且与疾病严重程度相关。
  • 接受低分子肝素血栓预防的高加索COVID-19患者罕见发生显性DIC,DIC倾向于局限于晚期疾病。
  • 中国队列研究报告D-二聚体升高且与总生存呈负相关。
  • 种族对血栓风险有显著影响,中国人血栓风险较高加索人低3-4倍,非裔美国人风险显著更高。

临床怎么用

  • 高加索COVID-19患者接受低分子肝素血栓预防时,显性DIC罕见且多限于晚期,临床识别应关注肺特异性血管病(PIC)而非DIC。
  • 评估COVID-19凝血病时需考虑种族对血栓风险的影响。

局限性

  • 严重COVID-19的病理生理学仍知之甚少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although the pathophysiology underlying severe COVID19 remains poorly understood, accumulating data suggest that a lung-centric coagulopathy may play an important role. Elevated D-dimer levels which correlated inversely with overall survival were recently reported in Chinese cohort studies. Critically however, ethnicity has major effects on thrombotic risk, with a 3-4-fold lower risk in Chinese compared to Caucasians and a significantly higher risk in African-Americans. In this study, we investigated COVID19 coagulopathy in Caucasian patients. Our findings confirm that severe COVID19 infection is associated with a significant coagulopathy that correlates with disease severity. Importantly however, Caucasian COVID19 patients on low molecular weight heparin thromboprophylaxis rarely develop overt disseminated intravascular coagulation (DIC). In rare COVID19 cases where DIC does develop, it tends to be restricted to late-stage disease. Collectively, these data suggest that the diffuse bilateral pulmonary inflammation observed in COVID19 is associated with a novel pulmonary-specific vasculopathy termed pulmonary intravascular coagulopathy (PIC) as distinct to DIC. Given that thrombotic risk is significantly impacted by race, coupled with the accumulating evidence that coagulopathy is important in COVID19 pathogenesis, our findings raise the intriguing possibility that pulmonary vasculopathy may contribute to the unexplained differences that are beginning to emerge highlighting racial susceptibility to COVID19 mortality.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Fogarty H, Townsend L, Ni Cheallaigh C, et al. COVID19 coagulopathy in Caucasian patients. Br J Haematol. 2020. PMID: 32330308. doi:10.1111/bjh.16749

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。